Skip to main content
. 2005 Nov 22;107(7):2882–2888. doi: 10.1182/blood-2005-09-3552

Figure 6.

Figure 6.

BLyS promotes proliferation of WM cells. (A) CD19+CD138+ cells (0.1 × 106 cells/well) from WM patients (n = 3) were cultured in 96-well round-bottom plates in the presence or absence of 100 ng/mL BLyS or 10 μg/mL anti-Ig Ab, each alone or in combination, for 5 days at 37°C in the presence of 5% CO2. Values represent the mean of triplicate values ± SD. (B) TACI-Ig fusion protein blocks BLyS-induced proliferation of malignant B cells. A fourth WM patient sample (WM15) was used to show that BLyS-induced proliferation of malignant B cells is inhibited in the presence of TACI-Ig fusion protein.